Related Experiment Video
Updated: Jan 8, 2026

Assays for Studying the Role of Vitronectin in Bacterial Adhesion and Serum Resistance
Published on: October 16, 2018
A novel phosvitin anticoagulant peptide: preparation, identification and interaction with thrombin
Yaxin Zhang1, Binfei Lv1, Shan Gao1
1Tianjin Key Laboratory of Food Quality and Health, College of Food Science and Engineering, Tianjin University of Science & Technology, Tianjin, PR China.
Background:
Searching for natural phosphorylated peptides as thrombin inhibitors is a good strategy for coagulation intervention. Phosvitin is one of the most phosphorylated proteins and has an anticoagulant effect by inhibiting thrombin.
Results:
The preparation of phosvitin hydrolysate was optimized by two-step enzymatic hydrolysis in this study, resulting in a significant enhancement of its thrombin inhibitory activity. After chromatography purification, the P4 fraction exhibiting the highest thrombin inhibitory activity was isolated. It significantly prolonged the thrombin time and the activated partial thromboplastin time, indicating inhibition of the endogenous and common coagulation pathways. pSSKpSSNpSpSK, identified from the P4 fraction, exhibited a high proportion among total peptides and strong thrombin affinity, primarily binding to exosite I of thrombin via electrostatic interactions. Polyphosphorylation of peptides played a critical role in thrombin inhibition. Additionally, pSSKpSSNpSpSK may interfere with blood coagulation through the lipid and atherosclerotic signaling pathway.
Conclusion:
The present study successfully isolated polyphosphorylated peptides from phosvitin, demonstrating that their core components exert anticoagulant effects by inhibiting thrombin and interfering with signaling pathways, laying a promising theoretical foundation for developing anticoagulant functional foods. © 2025 Society of Chemical Industry.
More Related Videos
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care

